Comedian Katherine Ryan revealed she has the deadliest form of skin cancer today, after being told by doctors twice that she ...

By Professor H. Peter Soyer and Professor Monika Jander , The University of QueenslandThe potential for 3D photography to ...

advanced squamous cell carcinoma (SCC), advanced basal cell carcinoma (BCC), advanced cutaneous squamous cell carcinoma (CSCC), and advanced non-small cell lung cancer (NSCLC). Last week ...

The practice of Dr. Allan Mineroff in Hatfield Township, Montgomery County, has joined Dermatology Partners, a privately owned, physician-led dermatology group specializing in medical and surgical ...

Angiosarcoma is a rare and aggressive malignant neoplasm that arises from endothelial cells of blood or lymphatic vessels, ...

Colorectal cancer is one of the most treatable cancers, especially when detected early. For those in advanced stages, ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...

With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in ...

Now, as a scientist at the University of Pennsylvania, Charly is working to rewrite the future of cancer treatment.

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

Chung et al. examine the levels of glycoprotein non-metastatic melanoma protein B (GPNMB) in the blood of patients with renal cell carcinoma who acquire resistance to immune checkpoint inhibitor ...